Ratios (Summary)

Abbott Laboratories, long-term (investment) activity ratios

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Net fixed asset turnover 3.60 3.66 3.56 3.41 3.70
Total asset turnover 0.36 0.40 0.49 0.49 0.51
Equity turnover 0.89 1.02 0.96 0.94 0.87

Source: Based on data from Abbott Laboratories Annual Reports

Ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Abbott Laboratories's net fixed asset turnover improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017 not reaching 2015 level.
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Abbott Laboratories's total asset turnover deteriorated from 2015 to 2016 and from 2016 to 2017.
Equity turnover An activity ratio calculated as total revenue divided by shareholders' equity. Abbott Laboratories's equity turnover improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Top


Net Fixed Asset Turnover

Abbott Laboratories, net fixed asset turnover calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net sales 27,390  20,853  20,405  20,247  21,848 
Net property and equipment 7,607  5,705  5,730  5,935  5,905 
Ratio
Net fixed asset turnover1 3.60 3.66 3.56 3.41 3.70
Benchmarks
Net Fixed Asset Turnover, Competitors
AbbVie Inc. 10.07 9.85 8.91 8.03 8.18
Allergan PLC 8.93 9.04 9.58 8.19 5.37
Amgen Inc. 4.37 4.41 4.27 3.70 3.40
Biogen Inc. 3.86 4.58 4.92 5.50 3.96
Bristol-Myers Squibb Co. 4.15 3.90 3.75 3.59 3.58
Celgene Corp. 12.12 12.03 11.25 11.77 10.72
Eli Lilly & Co. 2.59 2.57 2.48 2.46 2.90
Gilead Sciences Inc. 7.79 10.45 14.13 14.62 9.26
Johnson & Johnson 4.50 4.52 4.41 4.61 4.27
Merck & Co. Inc. 3.23 3.31 3.16 3.22 2.94
Pfizer Inc. 3.79 3.97 3.55 4.22 4.16
Regeneron Pharmaceuticals Inc. 2.49 2.33 2.57 2.89 3.99
Net Fixed Asset Turnover, Sector
Pharmaceuticals & Biotechnology 4.31 4.44 4.33 4.33 3.96
Net Fixed Asset Turnover, Industry
Health Care 7.11 7.33 7.00 6.93 6.50

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Net fixed asset turnover = Net sales ÷ Net property and equipment
= 27,390 ÷ 7,607 = 3.60

Ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Abbott Laboratories's net fixed asset turnover improved from 2015 to 2016 but then slightly deteriorated from 2016 to 2017 not reaching 2015 level.

Top


Total Asset Turnover

Abbott Laboratories, total asset turnover calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net sales 27,390  20,853  20,405  20,247  21,848 
Total assets 76,250  52,666  41,247  41,275  42,953 
Ratio
Total asset turnover1 0.36 0.40 0.49 0.49 0.51
Benchmarks
Total Asset Turnover, Competitors
AbbVie Inc. 0.40 0.39 0.43 0.72 0.64
Allergan PLC 0.13 0.11 0.11 0.25 0.38
Amgen Inc. 0.27 0.28 0.29 0.28 0.28
Biogen Inc. 0.52 0.50 0.55 0.68 0.58
Bristol-Myers Squibb Co. 0.62 0.58 0.52 0.47 0.42
Celgene Corp. 0.43 0.40 0.34 0.44 0.48
Eli Lilly & Co. 0.51 0.55 0.56 0.53 0.66
Gilead Sciences Inc. 0.37 0.53 0.62 0.71 0.48
Johnson & Johnson 0.49 0.51 0.53 0.57 0.54
Merck & Co. Inc. 0.46 0.42 0.39 0.43 0.42
Pfizer Inc. 0.31 0.31 0.29 0.29 0.30
Regeneron Pharmaceuticals Inc. 0.67 0.70 0.73 0.73 0.71
Total Asset Turnover, Sector
Pharmaceuticals & Biotechnology 0.37 0.38 0.38 0.44 0.43
Total Asset Turnover, Industry
Health Care 0.54 0.55 0.53 0.61 0.62

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Total asset turnover = Net sales ÷ Total assets
= 27,390 ÷ 76,250 = 0.36

Ratio Description The company
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Abbott Laboratories's total asset turnover deteriorated from 2015 to 2016 and from 2016 to 2017.

Top


Equity Turnover

Abbott Laboratories, equity turnover calculation, comparison to benchmarks

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net sales 27,390  20,853  20,405  20,247  21,848 
Total Abbott shareholders' investment 30,897  20,538  21,211  21,526  25,171 
Ratio
Equity turnover1 0.89 1.02 0.96 0.94 0.87
Benchmarks
Equity Turnover, Competitors
AbbVie Inc. 5.54 5.53 5.79 11.46 4.18
Allergan PLC 0.22 0.19 0.20 0.46 0.91
Amgen Inc. 0.86 0.73 0.75 0.75 0.82
Biogen Inc. 0.97 0.94 1.15 0.90 0.80
Bristol-Myers Squibb Co. 1.77 1.20 1.16 1.07 1.08
Celgene Corp. 1.87 1.69 1.55 1.16 1.14
Eli Lilly & Co. 1.97 1.52 1.37 1.28 1.31
Gilead Sciences Inc. 1.26 1.59 1.73 1.59 0.95
Johnson & Johnson 1.27 1.02 0.98 1.07 0.96
Merck & Co. Inc. 1.17 0.99 0.88 0.87 0.88
Pfizer Inc. 0.74 0.89 0.75 0.70 0.68
Regeneron Pharmaceuticals Inc. 0.96 1.09 1.12 1.11 1.08
Equity Turnover, Sector
Pharmaceuticals & Biotechnology 0.98 0.93 0.88 0.96 0.93
Equity Turnover, Industry
Health Care 1.39 1.35 1.24 1.37 1.34

Source: Based on data from Abbott Laboratories Annual Reports

2017 Calculations

1 Equity turnover = Net sales ÷ Total Abbott shareholders' investment
= 27,390 ÷ 30,897 = 0.89

Ratio Description The company
Equity turnover An activity ratio calculated as total revenue divided by shareholders' equity. Abbott Laboratories's equity turnover improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Top